Orthogonal Six-Base Universal Sequences for bDNA Assays

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The existing branched DNA (bDNA) assays face challenges with background noise due to non-specific hybridization, particularly in multiplex formats, which reduces sensitivity and makes it difficult to accurately detect and genotype viruses, retroviruses, SNPs, and cytokines.

Innovation Solution

Development of highly orthogonal six-base universal sequences comprising four natural bases and two non-natural bases, such as isoguanosine and isocytosine, which are designed to minimize cross-hybridization, with a melting temperature of approximately 80-85°C, allowing for specific binding and reduced non-specific interactions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional four-base universal sequences are used in bDNA assays, then the assay can detect targets, but background noise increases due to non-specific hybridization

Engineering Contradiction:
Improvespecificity of hybridizationVSAvoidbackground noise
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent changes the chemical parameter of the base pairing system by introducing two non-natural bases (iso-G and iso-C) that form Watson-Crick base pairs with each other but do not hybridize with natural bases. This parameter change creates a chemically distinct hybridization system that eliminates cross-reactivity between universal sequences and target sequences, thereby reducing background noise while maintaining detection capability

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite hybridization system that combines four natural bases (A, T, G, C) and two non-natural bases (iso-G, iso-C) in the same oligonucleotide sequence. This composite material approach allows the universal sequence to contain both natural bases for binding to the solid support and non-natural bases for specific binding to target sequences, while preventing non-specific hybridization through the orthogonal chemistry of iso-G/iso-C pairs

Inventive Principle:
Principle #40Composite materials

2Reliability

If six-base universal sequences with non-natural bases are used, then cross-reactivity is minimized, but sequence design and synthesis complexity increases

Engineering Contradiction:
Improveorthogonality of sequencesVSAvoidsequence design complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent segments the oligonucleotide sequence into distinct functional regions: a 5' region containing natural bases for solid support binding, a middle region with non-natural iso-G/iso-C bases for specific target binding, and a 3' region with natural bases for probe binding. This segmentation allows each region to be optimized independently for its specific function while maintaining overall sequence orthogonality

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent applies local quality by assigning different base compositions to different regions of the oligonucleotide. The 5' end uses natural bases for general binding, the central portion uses non-natural iso-G/iso-C bases for specific orthogonal interactions, and the 3' end uses natural bases for probe hybridization. This local differentiation optimizes each region's function while maintaining overall sequence performance

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The use of these universal sequences significantly improves the accuracy and specificity of bDNA assays by minimizing cross-reactivity, enabling the detection of low viral loads and precise genotyping of SNPs, and enhancing the sensitivity of cytokine mRNA quantitation.

Implementation Method 1

The bDNA assay is used to quantify RNA and DNA targets from a variety of sources. The sensitivity and specificity of the assay are derived in part through the judicious choice of oligonucleotide probes that constitute the probe set.

Methodology Applied
Scientific EffectHybridization: Chemical Bonding

Implementation Method 2

Iso-G and iso-C form standard Watson and Crick interactions with each other; however, because the hydrogen bonding pattern between the iso-G and iso-C is different from the hydrogen bonding pattern between the natural bases, there is no interaction between iso-G and iso-C and the natural bases.

Methodology Applied
Scientific EffectWatson and Crick interactions: Chemical Bonding

Implementation Method 3

Iso-G and iso-C form standard Watson and Crick interactions with each other; however, because the hydrogen bonding pattern between the iso-G and iso-C is different from the hydrogen bonding pattern between the natural bases, there is no interaction between iso-G and iso-C and the natural bases.

Methodology Applied
Scientific EffectHydrogen bonding: Chemical Bonding

Implementation Method 4

The DNA or RNA targets are labeled using a large number (typically>30) target-specific oligonucleotides called label extender (LE) probes, which mediate the hybridization of bDNA amplifier molecules to the CEs.

Methodology Applied
Scientific EffectHybridization: Chemical Bonding

Data Source

PatentUS8063196B2Highly orthogonal universal sequences for use in nucleic acid assays
Publication Date: 2011.11.22 SIEMENS HEALTHCARE DIAGNOSTICS INC
  • US8063196B2 patent drawing
  • US8063196B2 patent drawing
  • US8063196B2 patent drawing

AI summary

The invention provides a set of highly orthogonal six-code universal sequences for use in bDNA singleplex and multiplex nucleic acid hybridization assays. The six-code orthogonal sequences do not cross-hybridize and thus, minimize or eliminate the 3-mer cross-hybridization inherent in the second and third generation bDNA assays. The highly orthogonal universal sequences may be used in singleplex or multiplex bDNA assays quantitatively and qualitatively to determine mRNA levels in a sample; to screen for and genotype targets, such as viruses, that are present in low volumes in a sample; to screen for and genotype SNPs; and to measure changes in the amount of a gene in a sample such as when gene amplifications or deletions occur. The highly orthogonal universal sequences may also be used as universal capture probes to selectively bind assay components in a way that facilitates their further analysis.